The course is sponsored by the UCLA Neuropsychiatric Institute. This program is supported by an unrestricted educational grant from Bristol-Myers Squibb Company and Otsuka Pharmaceuticals.

Note: It is the policy of the UCLA Neuropsychiatric Institute that the sponsor and faculty disclose real or apparent conflicts of interest relating to the topics of this educational activity.